2017 Forecast sales of PliaglisSales will begin in the US in Q1 of 2017. Canadian and Mexican sales should follow , later in 2017.
In 2013, first sales of Pliaglis was begun when Galderma distributed in the U.S. without a sales force to actively promote it.
Distribution and manufacturing were by a third party.
Annual sales of Pliaglis in 2013 were about $9.5 million US .
In early 2014, Galderma started promoting Pliaglis in the US with a small sales force.
Sales began to increase and peaked in 2015 when Pliaglis sales amounted to about $18.5 million US.
Galderma than removed its sales force and sales dseclined to near zero in 2016, when Crescita reacquired the rights.
So, for 2017, with a small sales force, reformulated Pliaglis sales in the US could be significant perhaps as high as $10 million US..